Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine B Geiersbach

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Archives of Pathology & Laboratory Medicine|October 6, 2011
Microsatellite instability and colorectal cancerKatherine B Geiersbach, Wade S Samowitz
Prenatal Diagnosis|November 10, 2012
Rapid aneusomy detection in products of conception using the KaryoLite™ BACs-on-Beads™ assayChristian N Paxton, Arthur R Brothman, Katherine B Geiersbach
Archives of Pathology & Laboratory Medicine|December 14, 2016
RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference LaboratoryLing Hui, Katherine B Geiersbach, Erinn Downs-Kelly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2018
Reply to Commentary on 'HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features'Rachel L Stewart, Evin H Gulbahce, Katherine B Geiersbach, et al.
Archives of Pathology & Laboratory Medicine|June 30, 2012
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testingMichelle L Wallander, Katherine B Geiersbach, Sheryl R Tripp, et al.
Clinical Chemistry|March 12, 2015
Copy number assessment by competitive PCR with limiting deoxynucleotide triphosphates and high-resolution meltingLuming Zhou, Robert A Palais, Christian N Paxton, et al.
Journal of Cutaneous Pathology|June 5, 2024
A case of diagnostic uncertainty: High-grade melanocytoma versus balloon cell melanoma in a pediatric patientSerena Shimshak, Olayemi Sokumbi, Ruifeng Guo, et al.
Cancer Genetics|February 23, 2020
Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working groupKatherine B Geiersbach, Hui Chen, Rajyasree Emmadi, et al.
Human Pathology|April 24, 2023
Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinomaWilliam R Sukov, Jain Zhou, Katherine B Geiersbach, et al.
American Journal of Clinical Pathology|February 1, 2018
Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization ResultsGloria T Haskell, Yajuan J Liu, Hui Chen, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Archives of Pathology & Laboratory Medicine|October 6, 2011
Microsatellite instability and colorectal cancerKatherine B Geiersbach, Wade S Samowitz
Prenatal Diagnosis|November 10, 2012
Rapid aneusomy detection in products of conception using the KaryoLite™ BACs-on-Beads™ assayChristian N Paxton, Arthur R Brothman, Katherine B Geiersbach
Archives of Pathology & Laboratory Medicine|December 14, 2016
RAI1 Alternate Probe Identifies Additional Breast Cancer Cases as Amplified Following Equivocal HER2 Fluorescence In Situ Hybridization Testing: Experience From a National Reference LaboratoryLing Hui, Katherine B Geiersbach, Erinn Downs-Kelly, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 19, 2018
Reply to Commentary on 'HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features'Rachel L Stewart, Evin H Gulbahce, Katherine B Geiersbach, et al.
Archives of Pathology & Laboratory Medicine|June 30, 2012
Comparison of reverse transcription-polymerase chain reaction, immunohistochemistry, and fluorescence in situ hybridization methodologies for detection of echinoderm microtubule-associated proteinlike 4-anaplastic lymphoma kinase fusion-positive non-small cell lung carcinoma: implications for optimal clinical testingMichelle L Wallander, Katherine B Geiersbach, Sheryl R Tripp, et al.
Clinical Chemistry|March 12, 2015
Copy number assessment by competitive PCR with limiting deoxynucleotide triphosphates and high-resolution meltingLuming Zhou, Robert A Palais, Christian N Paxton, et al.
Journal of Cutaneous Pathology|June 5, 2024
A case of diagnostic uncertainty: High-grade melanocytoma versus balloon cell melanoma in a pediatric patientSerena Shimshak, Olayemi Sokumbi, Ruifeng Guo, et al.
Cancer Genetics|February 23, 2020
Current concepts in breast cancer genomics: An evidence based review by the CGC breast cancer working groupKatherine B Geiersbach, Hui Chen, Rajyasree Emmadi, et al.
Human Pathology|April 24, 2023
Frequency of HER2 protein overexpression and HER2 gene amplification in endometrial clear cell carcinomaWilliam R Sukov, Jain Zhou, Katherine B Geiersbach, et al.
American Journal of Clinical Pathology|February 1, 2018
Integrated Analysis of HER2 Copy Number by Cytogenomic Microarray in Breast Cancers With Nonclassical In Situ Hybridization ResultsGloria T Haskell, Yajuan J Liu, Hui Chen, et al.
Pageof 5